Evidence map›Paper›PMID 41975501›Full record

ArticleInfectious diseases of poverty2026

Access to praziquantel in Italy: persistent gaps and ongoing responses amid a Europe-wide shortage.

Rosalia Marrone, Cristiano Camponi, Silvia Cammarata, Domenico Di Giorgio, Robert Giovanni Nisticò, Christian Napoli

Abstract readEditorial
PubMed Full text at PMC Publisher
In one paragraph

Article in Infectious diseases of poverty, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Rosalia MarroneNational Institute for Migration and Poverty, Rome, Italy. rosalia.marrone@inmp.it.
Cristiano CamponiNational Institute for Migration and Poverty, Rome, Italy.
Silvia CammarataItalian Medicines Agency, Rome, Italy.
Domenico Di GiorgioItalian Medicines Agency, Rome, Italy.
Robert Giovanni NisticòItalian Medicines Agency, Rome, Italy.
Christian NapoliNational Institute for Migration and Poverty, Rome, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In Italy, praziquantel (PZQ) is not registered for human use and can be imported from European countries where it is authorized, according to a specific ministerial decree. Recent Europe-wide shortages, however, have made this route impractical, resulting in the unavailability of this essential medicine. This editorial summarizes historical gaps in supply, the actions undertaken, and the interim solutions implemented to restore PZQ access in Italy. The Italian experience highlights broader challenges related to essential medicines and underscores the need for coordinated national and European strategies to ensure stable and equitable availability.

Indexed as

AnthelminticsHealth Services AccessibilityPraziquantelEuropeHumansItalyAnthelminticsPraziquantelDrug importationDrug shortageEssential medicineInfectious diseases of povertyItalyMedicine accessMigrant healthNeglected tropical diseasesPraziquantelSchistosomiasis

Identifiers

PMID41975501
PMCPMC13072471

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.